Grosspeter Tower – Basel’s sustainable model skyscraper
With the ambitious goal of being a zero-emission building, Basel’s youngest skyscraper Grosspeter Tower was constructed to cover its own power requirements. Already during the construction phase, this impressive 78 meter office building by Burckhardt+Partner was awarded numerous prizes for its unique sustainable design and its building fabric. In particular, the façade, which is half windows, half integrated photovoltaic system - the first of its kind in Europe – make the building an efficient powerhouse.
Grosspeter Tower (img: Adriano Biondo)
After the official opening of Grosspeter Tower and move-in of Bayer in summer 2018, other well-known tenants have settled in the tower or will move into their newly developed offices in the coming months. Among others, Basel’s first Spaces Coworking solution operated by IWG will open its doors on the top floors from April 2019.
IWG – a leading provider of flexible workspaces – is strongly expanding in the Basel Region, aiming at establishing up to 10 new centers within the next three years. IWG has been a strong partner of BaselArea.swiss since opening its first center in Basel and has since hosted numerous foreign companies while starting up their business operations in the Basel region. To strengthen this partnership, BaselArea.swiss collaborates with IWG to offer its newly established Swiss entities of foreign companies and startups a soft start by providing free workspace for the first two months.
The building is ideally located in Basel’s business district, just a short walk from the railway station, shops and restaurants and has direct highway access. With the attached Ibis Styles, it offers on-site accommodation for business partners and customers.
Share this article
You might also be interested in
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.Read More